Table 1.
Parameter | Amnioac (n=444) | Non-amniobc (n=444) | p-Value | Standardized difference |
---|---|---|---|---|
Age, year | 58 (53–62) | 58 (53–63) | 0.6 | 0.09 |
PSA, ng/mL | 5.2 (3.9–7) | 5.3 (4.2–7.1) | 0.3 | 0.03 |
Body mass index, kg/m2 | 27 (24.8–29.4) | 27 (24.8–29.7) | 0.8 | 0.01 |
Preoperative SHIM score | 24 (21–25) | 24 (21–25) | 0.3 | 0.05 |
Preoperative AUASS | 5.5 (3–12) | 7.96 (3–11) | 1 | 0.03 |
Clinical stage | 0.1 | |||
T1c | 396 (89.2) | 388 (87.4) | −0.06 | |
T2a | 38 (8.6) | 53 (11.9) | 0.11 | |
T2b | 7 (1.6) | 2 (0.5) | −0.11 | |
T2c | 3 (0.7) | 1 (0.2) | −0.07 | |
Charlson comorbidity index | 1 (1–2) | 1 (1–2) | 0.9 | 0.07 |
Charlson comorbidity index | 0.9 | |||
0–1 | 229 (51.6) | 233 (52.5) | 0.02 | |
2–3 | 204 (45.9) | 199 (44.8) | −0.02 | |
≥4 | 11 (2.5) | 12 (2.7) | 0.01 | |
Biopsy preoperative ISUP grade group | 0.8 | |||
Grade group 1 | 197 (44.4) | 194 (43.7) | −0.01 | |
Grade group 2 | 160 (36.0) | 159 (35.8) | −0.01 | |
Grade group 3 | 56 (12.6) | 54 (12.2) | −0.01 | |
Grade group 4 | 26 (5.9) | 34 (7.7) | 0.07 | |
Grade group 5 | 5 (1.1) | 3 (0.7) | −0.05 | |
Degree of NS | 0.9 | |||
Bilateral partial | 119 (26.8) | 116 (26.1) | −0.01 | |
Bilateral full | 325 (73.2) | 328 (73.9) | 0.01 | |
No NS | 0 | 0 | 0 |
SHIM, Sexual Health Inventory for Men; AUASS, American Urological Association symptom score; ISUP, International Society of Urological Pathology; PSA, prostate-specific antigen; NS, nerve-sparing.
Patients undergoing NS robotic-assisted radical prostatectomy with dehydrated human amnion chorion membrane allograft placement.
Patients undergoing NS robotic-assisted radical prostatectomy without dehydrated human amnion chorion membrane allograft placement.
Values are presented as median (interquartile range) or n (%).